DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ursodiol (Ursodiol) - Maternal Drugs Affecting Foetus - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Maternal Drugs Affecting Foetus (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ursodiol where reactions include maternal drugs affecting foetus. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Ursodiol side effects in female

Reported by a individual with unspecified qualification from France on 2012-04-26

Patient: female

Reactions: Maternal Drugs Affecting Foetus, Dysmorphism, Caesarean Section, NO Adverse Event

Drug(s) suspected as cause:
Aspirin
    Dosage: 250 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Josacine / 00273602 / (Josamycin Propionate)
    Indication: Foetal Exposure During Pregnancy

Cellcept
    Dosage: 250 mg, bid, transplacental
    Indication: Foetal Exposure During Pregnancy

Innohep 1000 (Tinzaparin Sodium) Solution FOR Injection, 10000iu / .5ml
    Dosage: 0.5 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Prograf
    Dosage: 2.5 g, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Pentasa
    Indication: Foetal Exposure During Pregnancy

Ursodiol
    Dosage: 200 mg, qid, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Calcium Carbonate
    Dosage: 1 df, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Prednisolone
    Indication: Foetal Exposure During Pregnancy



Possible Ursodiol side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-05

Patient: female

Reactions: Congenital Nose Malformation, Maternal Drugs Affecting Foetus, Caesarean Section, Dysmorphism, Haematoma

Drug(s) suspected as cause:
Ursodiol
    Dosage: 200 mg, qid, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Calcium Carbonate
    Dosage: 1 df, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Innohep
    Dosage: 0.5 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Josacine / 00273602 / (Josamycin Propionate)
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Pentasa
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Prograf
    Dosage: 2.5 g, qd, transplacental
    Indication: Foetal Exposure During Pregnancy
    End date: 2009-05-15

Aspirin
    Dosage: 250 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Prednisolone
    Dosage: transplacental
    Indication: Foetal Exposure During Pregnancy

Cellcept
    Dosage: 250 mg, bid, transplacental
    Indication: Foetal Exposure During Pregnancy



Possible Ursodiol side effects in

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-09

Patient:

Reactions: LOW Birth Weight Baby, Maternal Drugs Affecting Foetus, Apgar Score LOW, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Ursodiol
    Dosage: 600 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Glycyrrhizic Acid (Glycyrrhizic Acid)
    Dosage: 60 mg, qd, unk
    Indication: Foetal Exposure During Pregnancy

Prednisolone
    Dosage: 60 mg, qd, transplacental, 10 mg, qd, transplacental, 25 mg, qd, transplacental
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Magnesium Sulfate



Possible Ursodiol side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2011-11-22

Patient: 34 year old female

Reactions: Maternal Drugs Affecting Foetus, Pruritus, Anaemia, Condition Aggravated, Cholestasis, Varices Oesophageal, Premature Labour, Foetal Growth Restriction, Premature Rupture of Membranes, Post Procedural Haemorrhage, Breech Presentation, Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ursodiol

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017